Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
15 Jul 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-goes-private-stay-afloat-after-no-partner-found-anti-infection-drug
25 Apr 2024
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-calls-time-sporegen-covid-collab-while-santhera-hands-lonodelestat-back-spexis
02 May 2023
// PHARMIWEB
https://www.pharmiweb.com/press-release/2023-05-02/destiny-pharma-and-sporegen-announce-update-from-research-collaboration-under-innovate-uk-grant-award-to-develop-a-biotherapeutic-treatment-spor-cov-for-covid-19-and-influenza
27 Feb 2023
// Paul Schloesser ENDPTS
https://endpts.com/uk-biotech-hands-off-mid-stage-c-difficile-drug-in-up-to-570m-deal/
24 Feb 2023
// Annalee Armstrong FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-seals-c-diff-therapys-phase-3-fate-sebela
18 Nov 2022
// PROACTIVEINVESTORS
https://www.proactiveinvestors.co.uk/companies/news/944950/destiny-pharma-targets-growth-as-anti-infection-treatments-return-to-prominence-944950.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?